Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Growth Potential of the Allergic Rhinitis Market, and How Will It Perform by 2034?

In recent years, there has been consistent growth in the allergic rhinitis market. This growth is expected to continue, with the market size rising from $15.22 billion in 2024 to $15.74 billion in 2025, translating to a compound annual growth rate (CAGR) of 3.4%. The historic growth in this market has been driven by factors such as exposure to allergens, environmental changes, increased public awareness, escalating pollution levels, advancements in allergic rhinitis research, and rising disposable incomes.

In the coming years, the market size for allergic rhinitis is anticipated to experience consistent growth. It is projected to reach $18.49 billion by 2029, with a compound annual growth rate (CAGR) of 4.1%. This growth during the estimated period can be associated with needs for preventive care, aging demographics, urban development, and healthcare expenditure. During the forecasted period, key trends will include biologics and monoclonal antibodies, digital healthcare options, strategies to avoid allergens, pediatric allergic rhinitis, and allergen detection technology.

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the allergic rhinitis Market?

The expected surge in the allergic rhinitis market can be attributed to intensified levels of environmental pollution and global climate change. Air pollution, referring to dangerous substances present in our Earth’s atmosphere, poses a serious threat to human health, the environment, and the air we breathe. Long-term fluctuations in climatic patterns, including temperature and precipitation, fall under climate change. The impression of air pollution on the increasing prevalence and exacerbation of allergic rhinitis, has been well established, underlining the complex connection between air quality and respiratory health concerns. In August 2024, the US Environmental Protection Agency reported that nearly 66 million tons of pollutants were added in the American atmosphere in 2023. Hence, the increase in air pollution levels and changing climate significantly propel the allergic rhinitis market growth. In the growth of the allergic rhinitis market, the use of increased corticosteroid treatment proves to be a significant propelling factor. Corticosteroid treatment, or steroid treatment, uses medications known as corticosteroids or steroids. Corticosteroid treatment is a common therapeutic approach to managing allergic rhinitis and helps alleviate the associated symptoms by reducing inflammation within the nasal passageways. In September 2023, an evaluation by the American Society for Clinical Pharmacology and Therapeutics reported an average usage of Oral corticosteroids as 6.8% in the U.S., 17.5% in Taiwan, and 2.2% in Denmark, with an annual increase varying between 0.1% to 0.17%. Most prescriptions were short bursts lasting between 1–29 days, usually recommended for healthy adults affected by conditions such as respiratory ailments. Conclusively, the rise in corticosteroid treatment for allergic rhinitis supports the growth of the allergic rhinitis market.

Request Your Free Allergic Rhinitis Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=12926&type=smp

Who Are the Major Companies Shaping the Competitive Landscape of the Allergic Rhinitis Market?

Major companies operating in the allergic rhinitis market are:

• Merck and Co. Inc._x000D_

• Bayer AG_x000D_

• Novartis AG_x000D_

• Sanofi-Aventis LLC._x000D_

• AstraZeneca PLC_x000D_

What Are the Key Emerging Trends in the Allergic Rhinitis Market for the Next Decade?

Leading enterprises in the allergic rhinitis market are creating groundbreaking medicines to maintain their industry footprint. For example, Hikma Pharmaceuticals PLC, a pharmaceutical company from the UK, and Glenmark Specialty S.A., a pharmaceutical outfit from Switzerland, secured approval for their product Ryaltris from the United States Food and Drug Administration (FDA), a federal agency from the US, in August 2022. Ryaltris, a pioneering fixed-dose combination medication, treats nasal and ocular symptoms of seasonal allergic rhinitis and comes in a user-friendly nasal spray, suitable for adults and children aged 12 and up. The therapeutic effect of relieving nasal symptoms begins to manifest within 15 minutes of administration.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report

How Are Market Segments in the Allergic Rhinitis Industry Positioned for Long-Term Growth?

The allergic rhinitis market covered in this report is segmented –

1) By Type: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis

2) By Treatment: Antihistamines, Corticosteroids, Immunotherapy, Decongestants, Other Treatments

3) By Test: Skin Test, IgE Radioallergosorbent (RAST) Test, Complete Blood Count

4) By Route Of Administration: Oral, Nasal, Other Route Of Administration

5) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Stores

Subsegments:

1) By Seasonal Allergic Rhinitis: Pollen Allergy, Mold Allergy

2) By Perennial Allergic Rhinitis: Dust Mite Allergy, Pet Allergy, Mold Allergy

3) By Occupational Allergic Rhinitis: Chemical Allergens, Biological Allergens

Which Regions Are Making a Mark in the Allergic Rhinitis Market Growth?

North America was the largest region in the allergic rhinitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in allergic rhinitis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

How Is the Allergic Rhinitis Market Categorized and Defined in the Industry?

Allergic rhinitis refers to an allergic reaction involving nasal inflammation brought on by an allergen, such as pollen, dust, mold, or animal skin flakes, resulting in sneezing, lung congestion, an itchy nose and a sore throat. Allergic rhinitis is treated with various allergy drugs in various dosage forms that help alleviate symptoms.

Browse Through More Similar Reports By The Business Research Company:

Allergy Diagnostics Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/allergy-diagnostics-global-market-report

Antibiotic Free Meat Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/antibiotic-free-meat-global-market-report

Allergy Immunotherapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: